BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a decline of 69.2% from the October 31st total of 1,300 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.1 days.

BioSyent Stock Performance

Shares of BIOYF remained flat at $8.05 during mid-day trading on Friday. 100 shares of the stock were exchanged, compared to its average volume of 2,237. BioSyent has a one year low of $5.93 and a one year high of $8.90. The business’s fifty day moving average price is $8.03 and its 200 day moving average price is $7.54.

BioSyent Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be paid a dividend of $0.0322 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a yield of 1.6%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.